-
1
-
-
84857793524
-
Decisions about dendritic cells: past, present, and future
-
Steinman RM. Decisions about dendritic cells: past, present, and future. Annu Rev Immunol 2012; 30(1): 1-22
-
(2012)
Annu Rev Immunol
, vol.30
, Issue.1
, pp. 1-22
-
-
Steinman, R.M.1
-
2
-
-
84858780815
-
Cancer immunotherapy via dendritic cells
-
Palucka K, Banchereau J. Cancer immunotherapy via dendritic cells. Nat Rev Cancer 2012; 12(4): 265-277
-
(2012)
Nat Rev Cancer
, vol.12
, Issue.4
, pp. 265-277
-
-
Palucka, K.1
Banchereau, J.2
-
3
-
-
84966862666
-
Dendritic Cell-Based Immunotherapy: state of the Art and Beyond
-
Bol KF, Schreibelt G, Gerritsen WR et al. Dendritic Cell-Based Immunotherapy: state of the Art and Beyond. Clin Cancer Res 2016; 22(8): 1897-1906
-
(2016)
Clin Cancer Res
, vol.22
, Issue.8
, pp. 1897-1906
-
-
Bol, K.F.1
Schreibelt, G.2
Gerritsen, W.R.3
-
4
-
-
84928195112
-
Cancer immunotherapy A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells
-
Carreno BM, Magrini V, Becker-Hapak M et al. Cancer immunotherapy. A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells. Science 2015; 348(6236): 803-808
-
(2015)
Science
, vol.348
, Issue.6236
, pp. 803-808
-
-
Carreno, B.M.1
Magrini, V.2
Becker-Hapak, M.3
-
5
-
-
84884721824
-
A phase IB study on intravenous synthetic mRNA electroporated dendritic cell immunotherapy in pretreated advanced melanoma patients
-
Wilgenhof S, Van Nuffel AM, Benteyn D et al. A phase IB study on intravenous synthetic mRNA electroporated dendritic cell immunotherapy in pretreated advanced melanoma patients. Ann Oncol 2013; 24(10): 2686-2693
-
(2013)
Ann Oncol
, vol.24
, Issue.10
, pp. 2686-2693
-
-
Wilgenhof, S.1
Van Nuffel, A.M.2
Benteyn, D.3
-
6
-
-
84883466843
-
A dendritic cell vaccine pulsed with autologous hypochlorous acid-oxidized ovarian cancer lysate primes effective broad antitumor immunity: from bench to bedside
-
Chiang CL, Kandalaft LE, Tanyi J et al. A dendritic cell vaccine pulsed with autologous hypochlorous acid-oxidized ovarian cancer lysate primes effective broad antitumor immunity: from bench to bedside. Clin Cancer Res 2013; 19(17): 4801-4815
-
(2013)
Clin Cancer Res
, vol.19
, Issue.17
, pp. 4801-4815
-
-
Chiang, C.L.1
Kandalaft, L.E.2
Tanyi, J.3
-
7
-
-
84873989551
-
Comparison of glioma-associated antigen peptide-loaded versus autologous tumor lysate-loaded dendritic cell vaccination in malignant glioma patients
-
Prins RM, Wang X, Soto H et al. Comparison of glioma-associated antigen peptide-loaded versus autologous tumor lysate-loaded dendritic cell vaccination in malignant glioma patients. J Immunother 2013; 36(2): 152-157
-
(2013)
J Immunother
, vol.36
, Issue.2
, pp. 152-157
-
-
Prins, R.M.1
Wang, X.2
Soto, H.3
-
8
-
-
84898733422
-
Intratumoral immunization: a new paradigm for cancer therapy
-
Marabelle A, Kohrt H, Caux C, Levy R. Intratumoral immunization: a new paradigm for cancer therapy. Clin Cancer Res 2014; 20(7): 1747-1756
-
(2014)
Clin Cancer Res
, vol.20
, Issue.7
, pp. 1747-1756
-
-
Marabelle, A.1
Kohrt, H.2
Caux, C.3
Levy, R.4
-
9
-
-
85007010443
-
Intratumoral delivery of immunotherapy-act locally, think globally
-
Aznar MA, Tinari N, Rullan AJ et al. Intratumoral delivery of immunotherapy-act locally, think globally. J Immunol 2017; 198(1): 31-39
-
(2017)
J Immunol
, vol.198
, Issue.1
, pp. 31-39
-
-
Aznar, M.A.1
Tinari, N.2
Rullan, A.J.3
-
11
-
-
84962747427
-
Designing therapeutic cancer vaccines by mimicking viral infections
-
Sultan H, Fesenkova VI, Addis D et al. Designing therapeutic cancer vaccines by mimicking viral infections. Cancer Immunol Immunother 2017; 66(2): 203-213
-
(2017)
Cancer Immunol Immunother
, vol.66
, Issue.2
, pp. 203-213
-
-
Sultan, H.1
Fesenkova, V.I.2
Addis, D.3
-
12
-
-
56549116047
-
Toll-like receptor and RIG-I-like receptor signaling
-
Kawai T, Akira S. Toll-like receptor and RIG-I-like receptor signaling. Ann N Y Acad Sci 2008; 1143: 1-20
-
(2008)
Ann N Y Acad Sci
, vol.1143
, pp. 1-20
-
-
Kawai, T.1
Akira, S.2
-
14
-
-
0016777909
-
A modified polyriboinosinicpolyribocytidylic acid complex that induces interferon in primates
-
Levy HB, Baer G, Baron S et al. A modified polyriboinosinicpolyribocytidylic acid complex that induces interferon in primates. J Infect Dis 1975; 132(4): 434-439
-
(1975)
J Infect Dis
, vol.132
, Issue.4
, pp. 434-439
-
-
Levy, H.B.1
Baer, G.2
Baron, S.3
-
15
-
-
0021950864
-
Immunotherapeutic potential in murine tumor models of polyinosinic-polycytidylic acid and poly-Llysine solubilized by carboxymethylcellulose
-
Talmadge JE, Adams J, Phillips H et al. Immunotherapeutic potential in murine tumor models of polyinosinic-polycytidylic acid and poly-Llysine solubilized by carboxymethylcellulose. Cancer Res 1985; 45: 1066-1072
-
(1985)
Cancer Res
, vol.45
, pp. 1066-1072
-
-
Talmadge, J.E.1
Adams, J.2
Phillips, H.3
-
16
-
-
84954053287
-
Cancer immunotherapy with immunomodulatory anti-CD137 and anti-PD-1 monoclonal antibodies requires BATF3-dependent dendritic cells
-
Sanchez-Paulete AR, Cueto FJ, Martinez-LopezMet al. Cancer immunotherapy with immunomodulatory anti-CD137 and anti-PD-1 monoclonal antibodies requires BATF3-dependent dendritic cells. Cancer Discov 2016; 6(1): 71-79
-
(2016)
Cancer Discov
, vol.6
, Issue.1
, pp. 71-79
-
-
Sanchez-Paulete, A.R.1
Cueto, F.J.2
Martinez-Lopez, M.3
-
17
-
-
84855486511
-
Synthetic double-stranded RNA induces innate immune responses similar to a live viral vaccine in humans
-
Caskey M, Lefebvre F, Filali-Mouhim A et al. Synthetic double-stranded RNA induces innate immune responses similar to a live viral vaccine in humans. J Exp Med 2011; 208(12): 2357-2366
-
(2011)
J Exp Med
, vol.208
, Issue.12
, pp. 2357-2366
-
-
Caskey, M.1
Lefebvre, F.2
Filali-Mouhim, A.3
-
18
-
-
84923089650
-
Therapeutic in situ autovaccination against solid cancers with intratumoral poly-ICLC: case report, hypothesis, and clinical trial
-
Salazar AM, Erlich RB, Mark A et al. Therapeutic in situ autovaccination against solid cancers with intratumoral poly-ICLC: case report, hypothesis, and clinical trial. Cancer Immunol Res 2014; 2(8): 720-724
-
(2014)
Cancer Immunol Res
, vol.2
, Issue.8
, pp. 720-724
-
-
Salazar, A.M.1
Erlich, R.B.2
Mark, A.3
-
19
-
-
85040443512
-
A Phase I trial using local regional treatment, nonlethal irradiation, intratumoral and systemic polyinosinic-polycytidylic acid polylysine carboxymethylcellulose to treat liver cancer: in search of the abscopal effect
-
de la Torre AN, Contractor S, Castaneda I et al. A Phase I trial using local regional treatment, nonlethal irradiation, intratumoral and systemic polyinosinic-polycytidylic acid polylysine carboxymethylcellulose to treat liver cancer: in search of the abscopal effect. J Hepatocell Carcinoma 2017; 4: 111-121
-
(2017)
J Hepatocell Carcinoma
, vol.4
, pp. 111-121
-
-
de la Torre, A.N.1
Contractor, S.2
Castaneda, I.3
-
20
-
-
79951978155
-
Induction of CD8+ T-cell responses against novel glioma-associated antigen peptides and clinical activity by vaccinations with (alpha)-type 1 polarized dendritic cells and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulose in patients with recurrent malignant glioma
-
Okada H, Kalinski P, Ueda R et al. Induction of CD8+ T-cell responses against novel glioma-associated antigen peptides and clinical activity by vaccinations with (alpha)-type 1 polarized dendritic cells and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulose in patients with recurrent malignant glioma. J Clin Oncol 2011; 29(3): 330-336
-
(2011)
J Clin Oncol
, vol.29
, Issue.3
, pp. 330-336
-
-
Okada, H.1
Kalinski, P.2
Ueda, R.3
-
21
-
-
82755189230
-
Pilot clinical trial of type 1 dendritic cells loaded with autologous tumor lysates combined with GM-CSF, pegylated IFN, and cyclophosphamide for metastatic cancer patients
-
Alfaro C, Perez-Gracia JL, Suarez N et al. Pilot clinical trial of type 1 dendritic cells loaded with autologous tumor lysates combined with GM-CSF, pegylated IFN, and cyclophosphamide for metastatic cancer patients. J Immunol 2011; 187(11): 6130-6142
-
(2011)
J Immunol
, vol.187
, Issue.11
, pp. 6130-6142
-
-
Alfaro, C.1
Perez-Gracia, J.L.2
Suarez, N.3
-
22
-
-
85019054219
-
A phase II trial of autologous dendritic cell vaccination and radiochemotherapy following fluorescenceguided surgery in newly diagnosed glioblastoma patients
-
Inoges S, Tejada S, de Cerio AL et al. A phase II trial of autologous dendritic cell vaccination and radiochemotherapy following fluorescenceguided surgery in newly diagnosed glioblastoma patients. J Transl Med 2017; 15(1): 104
-
(2017)
J Transl Med
, vol.15
, Issue.1
, pp. 104
-
-
Inoges, S.1
Tejada, S.2
de Cerio, A.L.3
-
23
-
-
79952711945
-
Gene expression profile correlates with T-cell infiltration and relative survival in glioblastoma patients vaccinated with dendritic cell immunotherapy
-
Prins RM, Soto H, Konkankit V et al. Gene expression profile correlates with T-cell infiltration and relative survival in glioblastoma patients vaccinated with dendritic cell immunotherapy. Clin Cancer Res 2011; 17(6): 1603-1615
-
(2011)
Clin Cancer Res
, vol.17
, Issue.6
, pp. 1603-1615
-
-
Prins, R.M.1
Soto, H.2
Konkankit, V.3
-
24
-
-
84937846973
-
Evolving synergistic combinations of targeted immunotherapies to combat cancer
-
Melero I, Berman DM, Aznar MA et al. Evolving synergistic combinations of targeted immunotherapies to combat cancer. Nat Rev Cancer 2015; 15: 457-472
-
(2015)
Nat Rev Cancer
, vol.15
, pp. 457-472
-
-
Melero, I.1
Berman, D.M.2
Aznar, M.A.3
-
25
-
-
85028829596
-
Oncolytic virotherapy promotes intratumoral T cell infiltration and improves anti-PD-1 immunotherapy
-
Ribas A, Dummer R, Puzanov I et al. Oncolytic virotherapy promotes intratumoral T cell infiltration and improves anti-PD-1 immunotherapy. Cell 2017; 170(6): 1109-1119. e1110
-
(2017)
Cell
, vol.170
, Issue.6
-
-
Ribas, A.1
Dummer, R.2
Puzanov, I.3
-
26
-
-
85018813817
-
Integrative development of a TLR8 agonist for ovarian cancer chemoimmunotherapy
-
Monk BJ, Facciabene A, Brady WE et al. Integrative development of a TLR8 agonist for ovarian cancer chemoimmunotherapy. Clin Cancer Res 2017; 23(8): 1955-1966
-
(2017)
Clin Cancer Res
, vol.23
, Issue.8
, pp. 1955-1966
-
-
Monk, B.J.1
Facciabene, A.2
Brady, W.E.3
-
27
-
-
85019984969
-
A phase 2, randomized, doubleblind, placebo-controlled study of chemo-immunotherapy combination using motolimod with pegylated liposomal doxorubicin in recurrent or persistent ovarian cancer: a Gynecologic Oncology Group partners study
-
Monk BJ, Brady MF, Aghajanian C et al. A phase 2, randomized, doubleblind, placebo-controlled study of chemo-immunotherapy combination using motolimod with pegylated liposomal doxorubicin in recurrent or persistent ovarian cancer: a Gynecologic Oncology Group partners study. Ann Oncol 2017; 28(5): 996-1004
-
(2017)
Ann Oncol
, vol.28
, Issue.5
, pp. 996-1004
-
-
Monk, B.J.1
Brady, M.F.2
Aghajanian, C.3
-
28
-
-
78049420571
-
In situ vaccination with a TLR9 agonist induces systemic lymphoma regression: a phase I/II study
-
Brody JD, Ai WZ, Czerwinski DK et al. In situ vaccination with a TLR9 agonist induces systemic lymphoma regression: a phase I/II study. J Clin Oncol 2010; 28(28): 4324-4332
-
(2010)
J Clin Oncol
, vol.28
, Issue.28
, pp. 4324-4332
-
-
Brody, J.D.1
Ai, W.Z.2
Czerwinski, D.K.3
-
29
-
-
84991790808
-
Abscopal effects of radiotherapy are enhanced by combined immunostimulatory mAbs and are dependent on CD8 T cells and crosspriming
-
Rodriguez-Ruiz ME, Rodriguez I, Garasa S et al. Abscopal effects of radiotherapy are enhanced by combined immunostimulatory mAbs and are dependent on CD8 T cells and crosspriming. Cancer Res 2016; 76(20): 5994-6005
-
(2016)
Cancer Res
, vol.76
, Issue.20
, pp. 5994-6005
-
-
Rodriguez-Ruiz, M.E.1
Rodriguez, I.2
Garasa, S.3
-
30
-
-
69949085196
-
Fractionated but not single-dose radiotherapy induces an immune-mediated abscopal effect when combined with anti-CTLA-4 antibody
-
Dewan MZ, Galloway AE, Kawashima N et al. Fractionated but not single-dose radiotherapy induces an immune-mediated abscopal effect when combined with anti-CTLA-4 antibody. Clin Cancer Res 2009; 15(17): 5379-5388
-
(2009)
Clin Cancer Res
, vol.15
, Issue.17
, pp. 5379-5388
-
-
Dewan, M.Z.1
Galloway, A.E.2
Kawashima, N.3
-
31
-
-
84937525789
-
Local radiotherapy and granulocyte-macrophage colony-stimulating factor to generate abscopal responses in patients with metastatic solid tumours: a proof-of-principle trial
-
Golden EB, Chhabra A, Chachoua A et al. Local radiotherapy and granulocyte-macrophage colony-stimulating factor to generate abscopal responses in patients with metastatic solid tumours: a proof-of-principle trial. Lancet Oncol 2015; 16: 795-803
-
(2015)
Lancet Oncol
, vol.16
, pp. 795-803
-
-
Golden, E.B.1
Chhabra, A.2
Chachoua, A.3
-
32
-
-
85003053854
-
An abscopal response to radiation and ipilimumab in a patient with metastatic non-small cell lung cancer
-
Golden EB, Demaria S, Schiff PB et al. An abscopal response to radiation and ipilimumab in a patient with metastatic non-small cell lung cancer. Cancer Immunol Res 2013; 1(6): 365-372
-
(2013)
Cancer Immunol Res
, vol.1
, Issue.6
, pp. 365-372
-
-
Golden, E.B.1
Demaria, S.2
Schiff, P.B.3
-
33
-
-
84974803082
-
Radiotherapy: changing the Game in Immunotherapy
-
Demaria S, Coleman CN, Formenti SC. Radiotherapy: changing the Game in Immunotherapy. Trends Cancer 2016; 2(6): 286-294
-
(2016)
Trends Cancer
, vol.2
, Issue.6
, pp. 286-294
-
-
Demaria, S.1
Coleman, C.N.2
Formenti, S.C.3
|